[go: up one dir, main page]

FI932114A0 - Maolspecifika erytrocyter och tromboerytrocyter - Google Patents

Maolspecifika erytrocyter och tromboerytrocyter

Info

Publication number
FI932114A0
FI932114A0 FI932114A FI932114A FI932114A0 FI 932114 A0 FI932114 A0 FI 932114A0 FI 932114 A FI932114 A FI 932114A FI 932114 A FI932114 A FI 932114A FI 932114 A0 FI932114 A0 FI 932114A0
Authority
FI
Finland
Prior art keywords
thromboerytrocytes
maolspecifika
erythrocytes
maolspecifika erythrocytes
Prior art date
Application number
FI932114A
Other languages
English (en)
Other versions
FI932114A (fi
Inventor
Barry S Coller
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Publication of FI932114A0 publication Critical patent/FI932114A0/fi
Publication of FI932114A publication Critical patent/FI932114A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI932114A 1990-11-09 1993-05-10 Maolspecifika erytrocyter och tromboerytrocyter FI932114A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61116490A 1990-11-09 1990-11-09
PCT/US1991/008430 WO1992008804A1 (en) 1990-11-09 1991-11-12 Erythrocytes and thrombo-erythrocytes as target specific agents

Publications (2)

Publication Number Publication Date
FI932114A0 true FI932114A0 (fi) 1993-05-10
FI932114A FI932114A (fi) 1993-07-01

Family

ID=24447889

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932114A FI932114A (fi) 1990-11-09 1993-05-10 Maolspecifika erytrocyter och tromboerytrocyter

Country Status (7)

Country Link
EP (1) EP0558645A4 (fi)
JP (1) JPH06504535A (fi)
KR (1) KR930702341A (fi)
AU (1) AU651643B2 (fi)
CA (1) CA2095925A1 (fi)
FI (1) FI932114A (fi)
WO (1) WO1992008804A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6017877A (en) * 1990-04-06 2000-01-25 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
GB9705787D0 (en) 1997-03-20 1997-05-07 Thrombosis Res Inst Modified dendroaspins
JP2002500168A (ja) * 1998-01-06 2002-01-08 トラステイーズ・オブ・ボストン・ユニバーシテイ 装飾赤血球
DE10038900A1 (de) * 2000-08-09 2002-03-07 Haemosys Gmbh Einfache Methode zum drug monitoring von GPIIb/IIIa-Rezeptor-Antagonisten
US7195919B2 (en) * 2003-12-19 2007-03-27 Beckman Coulter, Inc. Hematology controls for reticulocytes and nucleated red blood cells
DE102004054536A1 (de) * 2004-11-06 2006-05-11 Capsulution Nanoscience Ag Multimodal veränderte Zellen als zellulare Darreichungsformen für aktive Substanzen und als diagnostische Zellpartikel
JP2009523787A (ja) * 2006-01-19 2009-06-25 アイジーン インコーポレイテッド ペプチドを有効成分とする血管関連疾患の治療剤組成物
EP1849482A1 (en) * 2006-04-25 2007-10-31 Capsulution Nanoscience AG Multimodally altered cells as a form for administering active substances and as diagnostic particles
KR100824396B1 (ko) * 2006-10-10 2008-04-22 (주)케어젠 상피세포 성장인자의 활성을 가지는 펩타이드 및 그의 용도
CN101625267B (zh) * 2008-07-11 2011-07-20 财团法人工业技术研究院 热侦测系统及其侦测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
DE3218121A1 (de) * 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide
US4988621A (en) * 1985-05-24 1991-01-29 La Jolla Cancer Research Foundation Peptides in cell detachment and aggregation
JPS62190129A (ja) * 1986-02-18 1987-08-20 Green Cross Corp:The 制癌剤含有マイクロキヤリアの製造方法
US5000960A (en) * 1987-03-13 1991-03-19 Micro-Pak, Inc. Protein coupling to lipid vesicles

Also Published As

Publication number Publication date
KR930702341A (ko) 1993-09-08
JPH06504535A (ja) 1994-05-26
EP0558645A4 (en) 1994-07-06
WO1992008804A1 (en) 1992-05-29
AU651643B2 (en) 1994-07-28
AU9058891A (en) 1992-06-11
EP0558645A1 (en) 1993-09-08
FI932114A (fi) 1993-07-01
CA2095925A1 (en) 1992-05-10

Similar Documents

Publication Publication Date Title
FI923983A (fi) Kymotrypsinlika proteaser och deras inhibitorer
FI932285A (fi) Skyddshjaelm och loestagbart ansiktsskydd
FI930064A0 (fi) Anpassningsbar ekvalisator och mottagare
FI925480A (fi) Vattenloeslig pentacyklisk triterpenkomposition och foerfarande foer framstaellning av densamma
FI930076A0 (fi) Cysteamin innehaollande permanentningskomposition och foerfarande
FI88433C (fi) Anordning foer ingaongs- och utgaongsluft och luftkonditioneringsfoerfarande
DK0555292T3 (da) Hvirvelstrømsventil
FI922004A (fi) Maetningsfoerfarande och maetanordning
FI932114A0 (fi) Maolspecifika erytrocyter och tromboerytrocyter
FI931628A0 (fi) Identifieringsanordning och foerfarande foer saekerhetssystem
FI930104A (fi) Verktyg foer slagborrning och meissling och verktygshaollare foer saodana verktyg
FI89970B (fi) Foerfarande och anordning foer behandling av braensle
FI82677C (fi) Foerfarande och anordning foer loesgoerning av en utanfoer i en glasskiva skuren konturlinje staoende randzon
FI932420A (fi) Fartygsskrov och drivsystem eller liknande
FI925364A (fi) Foerfarande och anordning foer traodloes informationsoeverfoering
FI89612B (fi) Anordning och foerfarande foer avlaegsnande av traoder
FI931625A0 (fi) Kromaner och tiokromaner med retinoidlik aktivitet
FI924223A (fi) Foerfarande och apparat foer rengoeringskontroll
FI930002A0 (fi) Renings- och aotervinningsfoerfarande och anordning foer utfoerande av foerfarandet
FI892281A0 (fi) 3-pyrrolidinyltio-1-azabicyklo/3.2.0/ hept-2-en-2-karboxylsyraderivat och deras framstaellning.
FI925983A0 (fi) Maenniskans meg-csf-protein och foerfaranden
SE8902995L (sv) Trappa och trappsteg
FI925277A (fi) Monterbar och demonterbar laettbyggd bostad
BR9002261A (pt) Termokit-aquecedor e microsecadora
SE9004149D0 (sv) Driftsaettet och driftanordning

Legal Events

Date Code Title Description
FD Application lapsed